Seres Therapeutics to Initiate New SER-109 Clinical Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. MSTR

Go back to Seres Therapeutics to Initiate New SER-109 Clinical Study
(NASDAQ: MCRB) Delayed: 6.60 -0.01 (0.15%)
Previous Close $6.61    52 Week High $44.51 
Open $6.68    52 Week Low $8.05 
Day High $7.05    P/E N/A 
Day Low $6.31    EPS $0.00 
Volume 70,145